The large inner lumen of GluttonTM Intracranial Aspiration Catheter is 0.072", which brings greater aspiration for clinical practice, thereby improving the recanalization rate of aspiration and thrombus ability. Hydrophilic coating and multi-segment gradient transition design provide a stable passability guarantee for the overall support and high position of the aspiration catheter. It is commonly used during procedures to treat acute ischemic strokes. These conditions occur when blood flow to the brain is blocked by a clot, leading to tissue damage or death. By removing the clot quickly and effectively, clot aspiration catheters can help restore blood flow and prevent further damage.
Features&Advantages
1. Structure of coil and braid offers greater kink resistance, reducing the chances of catheter ovalization and derformation.
2. 0.072'' ultra-large lumen improves aspiration effiecency.
3. Distal multi-segment design allows for ease of navigation within the blood vessels.
4. It is constructed with a single lumen enabling easy steam shaping for improved navigation through tortuous vessel anatomy.
5. Multiple French sizes are available in a range of sizes for various clinical applications.
6. A hydrophilic coating reduces friction and facilitate smooth insertion and navigation.
7. A radiopaque marker is located at the distal end of the catheter for visualization under fluoroscopy.
Specifications
What is Ischemic stroke?
Ischemic stroke is one of three types of stroke. It is caused by a blockage in an artery that supplies blood to the brain. If circulation isn’t restored quickly, brain damage can be permanent. Ischemic stroke is also called brain ischemia and cerebral ischemia. The blockage caused by this stroke reduces the blood flow and oxygen to the brain, leading to damage or death of brain cells. Approximately 87 percent of all strokes are ischemic strokes. Ischemia product is used to treat ischemic stroke caused by cerebral thrombus, cerebral embolism, and vascular stenosis through thrombectomy or vasodilator. The core products include retriever stents, sapiration catheters, and expansion stents. Mechanical thrombectomy is the main development direction in the treatment of ischemic stroke in recent years, and has great potential for development.











